|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 120.20 PLN | +0.17% |
|
+1.52% | -11.75% |
| 05-27 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
| 05-15 | Scope Fluidics Q1 net loss at 13.5 million zlotys | RE |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -13.53 | -7.91 | -8.01 | -14.8 | -16.03 | |||||
Return on Total Capital | -24.2 | -8.87 | -8.56 | -17.56 | -18.91 | |||||
Return On Equity % | -61.77 | 191.96 | -9.08 | 57.57 | -30.03 | |||||
Return on Common Equity | -61.77 | 191.96 | -9.08 | 57.57 | -30.03 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | - | -115.84 | -265.89 | -901.53 | -3.64K | |||||
SG&A Margin | - | 5.78K | 4.6K | 21.48K | 38.63K | |||||
EBITDA Margin % | - | -6.13K | -5.51K | -24.26K | -46.21K | |||||
EBITA Margin % | - | -6.25K | -5.55K | -24.29K | -46.3K | |||||
EBIT Margin % | - | -6.25K | -5.56K | -24.8K | -47.28K | |||||
Income From Continuing Operations Margin % | - | 80.71K | -3.64K | 49.94K | -46.36K | |||||
Net Income Margin % | - | 78.83K | -3.64K | 49.94K | -46.36K | |||||
Net Avail. For Common Margin % | - | 80.71K | -3.64K | 49.94K | -46.36K | |||||
Normalized Net Income Margin | - | -3.63K | -2.26K | -11.52K | -28.78K | |||||
Levered Free Cash Flow Margin | - | 1.36K | -1.98K | -16K | -39.27K | |||||
Unlevered Free Cash Flow Margin | - | 1.47K | -1.94K | -15.9K | -39.14K | |||||
Asset Turnover | ||||||||||
Asset Turnover | - | 0 | 0 | 0 | 0 | |||||
Fixed Assets Turnover | - | 0.17 | 0.15 | 0.03 | 0.01 | |||||
Inventory Turnover (Average Inventory) | 1.8 | 1.82 | 2.73 | 1.06 | 0.97 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 5.13 | 68.03 | 14.71 | 13.77 | 13.06 | |||||
Quick Ratio | 2.14 | 67.87 | 14.5 | 13.54 | 12.55 | |||||
Operating Cash Flow to Current Liabilities | -2.49 | -5.69 | -3.1 | -2.21 | -3.61 | |||||
Days Outstanding Inventory (Average Inventory) | 202.81 | 200.92 | 133.68 | 344.66 | 375.45 | |||||
Average Days Payable Outstanding | 336.95 | 120.41 | 189.14 | 233.34 | 138.78 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 92.37 | 0.74 | 2.98 | 1.09 | 1.32 | |||||
Total Debt / Total Capital | 48.02 | 0.73 | 2.89 | 1.08 | 1.31 | |||||
LT Debt/Equity | 89.93 | 0.57 | 1.9 | 0.44 | 0.57 | |||||
Long-Term Debt / Total Capital | 46.75 | 0.56 | 1.84 | 0.44 | 0.56 | |||||
Total Liabilities / Total Assets | 72.35 | 3.81 | 20.26 | 15.34 | 17.1 | |||||
EBIT / Interest Expense | -3.93 | -33.96 | -103.18 | -154.7 | -241.23 | |||||
EBITDA / Interest Expense | -3.77 | -33.07 | -99.29 | -147.5 | -230.36 | |||||
(EBITDA - Capex) / Interest Expense | -3.81 | -33.28 | -106.23 | -162.9 | -257.46 | |||||
Total Debt / EBITDA | -1.37 | -0.1 | -0.09 | -0.05 | -0.05 | |||||
Net Debt / EBITDA | 0.47 | 13.4 | 3.07 | 4.83 | 3.43 | |||||
Total Debt / (EBITDA - Capex) | -1.35 | -0.1 | -0.08 | -0.05 | -0.04 | |||||
Net Debt / (EBITDA - Capex) | 0.46 | 13.31 | 2.87 | 4.37 | 3.07 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | - | - | 27.72 | -74.61 | -23.66 | |||||
Gross Profit, 1 Yr. Growth % | -31.16 | -28.66 | 193.16 | -13.92 | 208.04 | |||||
EBITDA, 1 Yr. Growth % | -13.9 | 147.36 | 13.42 | 11.83 | 45.41 | |||||
EBITA, 1 Yr. Growth % | -12.65 | 146.21 | 13.55 | 12.09 | 45.51 | |||||
EBIT, 1 Yr. Growth % | -12.65 | 146.21 | 13.67 | 13.26 | 45.54 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 3.9 | -2.88K | -105.76 | -448.26 | -170.87 | |||||
Net Income, 1 Yr. Growth % | 25.06 | -2.01K | -105.9 | -448.26 | -170.87 | |||||
Normalized Net Income, 1 Yr. Growth % | 2.97 | 100.06 | -20.44 | 29.42 | 90.74 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -0.82 | -2.87K | -105.7 | -448.26 | -160.98 | |||||
Inventory, 1 Yr. Growth % | -35.07 | 134.49 | 5.5 | 148.03 | 236.68 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -5.67 | 44.49 | 49.74 | 50.49 | 56.9 | |||||
Total Assets, 1 Yr. Growth % | 25.74 | 556.43 | -70.68 | 70.33 | 13.34 | |||||
Tangible Book Value, 1 Yr. Growth % | -37.44 | 4.9K | -75.73 | 80.91 | 10.89 | |||||
Common Equity, 1 Yr. Growth % | -37.61 | 4.84K | -75.69 | 80.84 | 10.99 | |||||
Cash From Operations, 1 Yr. Growth % | 129.62 | 31.78 | -32.32 | 31.73 | 83.69 | |||||
Capital Expenditures, 1 Yr. Growth % | -67.47 | 28.1 | 1.14K | 67.7 | 64.2 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 241.97 | -128.38 | -285.93 | 105.64 | 87.36 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 223.48 | -132.16 | -268.49 | 107.89 | 87.96 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | - | - | - | -43.06 | -55.98 | |||||
Gross Profit, 2 Yr. CAGR % | 24.53 | -29.92 | 44.62 | 58.86 | 62.84 | |||||
EBITDA, 2 Yr. CAGR % | 20.16 | 47.25 | 68.47 | 12.62 | 27.52 | |||||
EBITA, 2 Yr. CAGR % | 20.03 | 46.65 | 67.21 | 12.3 | 27.71 | |||||
EBIT, 2 Yr. CAGR % | 20.03 | 46.65 | 67.29 | 13.46 | 28.39 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 29.14 | 437.59 | 26.59 | -55.21 | 57.1 | |||||
Net Income, 2 Yr. CAGR % | 45 | 389.32 | 6.27 | -54.68 | 57.1 | |||||
Normalized Net Income, 2 Yr. CAGR % | 29.19 | 43.51 | 26.16 | 1.47 | 57.12 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 19.81 | 424.01 | 25.67 | -55.43 | 45.73 | |||||
Inventory, 2 Yr. CAGR % | - | 23.39 | 57.29 | 61.76 | 188.98 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 0.86 | 16.74 | 47.09 | 50.33 | 53.66 | |||||
Total Assets, 2 Yr. CAGR % | 39.27 | 187.3 | 38.73 | -29.33 | 38.95 | |||||
Tangible Book Value, 2 Yr. CAGR % | -2.29 | 278.9 | 248.26 | -33.73 | 41.63 | |||||
Common Equity, 2 Yr. CAGR % | -2.09 | 277.44 | 246.57 | -33.7 | 41.67 | |||||
Cash From Operations, 2 Yr. CAGR % | 100.83 | 70.7 | -5.56 | -5.58 | 55.56 | |||||
Capital Expenditures, 2 Yr. CAGR % | -41.29 | -35.45 | 299.28 | 356.85 | 65.94 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 145.17 | -18.12 | -27.36 | 95.54 | 96.29 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 138.47 | -14.53 | -26.39 | 87.16 | 97.67 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | - | - | - | - | -37.21 | |||||
Gross Profit, 3 Yr. CAGR % | 3.23 | 3.43 | 12.92 | 21.65 | 98.09 | |||||
EBITDA, 3 Yr. CAGR % | 45.13 | 53.77 | 35.5 | 46.96 | 22.63 | |||||
EBITA, 3 Yr. CAGR % | 34.76 | 52.51 | 34.67 | 45.89 | 22.43 | |||||
EBIT, 3 Yr. CAGR % | 34.76 | 52.51 | 34.71 | 46.9 | 23.28 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 42.24 | 259.31 | 18.52 | 77.38 | -47.81 | |||||
Net Income, 3 Yr. CAGR % | 59.84 | 242.72 | 12.19 | 57.85 | -47.39 | |||||
Normalized Net Income, 3 Yr. CAGR % | 42.15 | 49.46 | 17.89 | 27.24 | 25.23 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 35.37 | 241.26 | 16.13 | 76.51 | -50.52 | |||||
Inventory, 3 Yr. CAGR % | - | - | 17.11 | 83.07 | 106.53 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 91.85 | 13.69 | 26.84 | 48.36 | 52.49 | |||||
Total Assets, 3 Yr. CAGR % | 55.94 | 133.51 | 34.26 | 48.55 | -17.28 | |||||
Tangible Book Value, 3 Yr. CAGR % | 11.88 | 179.82 | 51.61 | 179.95 | -21.33 | |||||
Common Equity, 3 Yr. CAGR % | 4.43 | 179.73 | 51.29 | 179.01 | -21.28 | |||||
Cash From Operations, 3 Yr. CAGR % | 60.39 | 72.33 | 25.4 | 5.52 | 17.87 | |||||
Capital Expenditures, 3 Yr. CAGR % | 15.8 | -23.85 | 73.09 | 199.02 | 224.82 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 117.29 | 5.62 | 7.62 | 2.76 | 92.77 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 112.99 | 8.7 | 7.17 | 4.05 | 87.42 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | - | 195.27 | - | - | - | |||||
Gross Profit, 5 Yr. CAGR % | 27.61 | 3.11 | 18.14 | 22.8 | 30.72 | |||||
EBITDA, 5 Yr. CAGR % | 22.09 | 50.94 | 54.6 | 36.07 | 32.25 | |||||
EBITA, 5 Yr. CAGR % | 22.31 | 43.74 | 46.91 | 34.93 | 31.6 | |||||
EBIT, 5 Yr. CAGR % | 21.64 | 43.74 | 46.94 | 35.49 | 32.15 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 27.2 | 139.1 | 35.76 | 56.23 | 32.67 | |||||
Net Income, 5 Yr. CAGR % | 36.43 | 137.98 | 35.76 | 52.58 | 28.37 | |||||
Normalized Net Income, 5 Yr. CAGR % | 25.01 | 41.58 | 35.52 | 28.01 | 32.25 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 22.99 | 131.66 | 31.4 | 51.17 | 27.17 | |||||
Inventory, 5 Yr. CAGR % | - | 86.29 | - | - | 68.08 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 43.22 | 54.13 | 72.51 | 27.14 | 37.04 | |||||
Total Assets, 5 Yr. CAGR % | 52.14 | 79.28 | 48.81 | 44.77 | 36.11 | |||||
Tangible Book Value, 5 Yr. CAGR % | 57.15 | 89.62 | 50.81 | 57.27 | 47.54 | |||||
Common Equity, 5 Yr. CAGR % | 21.2 | 81.56 | 44.59 | 57.27 | 47.36 | |||||
Cash From Operations, 5 Yr. CAGR % | 41.84 | 41.69 | 28.79 | 35.47 | 36.69 | |||||
Capital Expenditures, 5 Yr. CAGR % | 97.21 | -5.54 | 89.99 | 55.92 | 70.19 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 54.15 | 27.74 | 30.19 | 35.13 | 36.87 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 52.32 | 30.01 | 29.74 | 35.09 | 36.9 |
- Stock Market
- Stocks
- SCP Stock
- Financials Scope Fluidics S.A.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















